Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

Serigne Lo; Jiawen Ma; Richard A Scolyer; Lauren E. Haydu; Jonathan R. Stretch; Robyn P.M. Saw; Omgo E. Nieweg; Kerwin F. Shannon; Andrew J. Spillane; Sydney Ch’ng; Graham J. Mann; Jeffrey E. Gershenwald; John F. Thompson; Alexander H. R. Varey

doi:10.1200/jco.19.02362

Back

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

Article 2020 en

Abstract

1 min read

A robust nomogram was developed that more accurately estimates the risk of SN positivity in patients with melanoma than currently available methods. The model only requires the input of 6 widely available clinicopathologic parameters. Importantly, the number of patients undergoing unnecessary SN biopsy would be significantly reduced compared with use of the MSKCC nomogram or the NCCN or ASCO/SSO guidelines, without losing sensitivity. An online calculator is available at www.melanomarisk.org.au.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Predicting sentinel node positivity in patients with primary cutaneous melanoma: an international multicentre study validating and refining the MIA risk calculator

Alexander H. R. Varey, Caroline A. Gjorup, Annette H. Chakera, L. Rosenkrantz Hölmich, Marc Moncrieff, Alastair D. MacKenzie Ross, Oliver Cassell, Jianhua Ma, Marie Brinch-Møller Weitemeyer, Roger Olofsson Bagge, Siri Klausen, Vinícius F. Calsavara, João Pedreira Duprat Neto, Eduardo Bertolli, Sydney Ch’ng, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Omgo E. Nieweg, Jonathan R. Stretch, G.J. Mann, Jenny L. C. Geh, R.C. Martin, C. Sharon, G.C. Karakousis, Mohammed Kashani–Sabet, George Adigbli, Mary‐Ann El‐Sharouni, Lauren E. Haydu, Jeffrey E. Gershenwald, Richard A Scolyer, John F. Thompson, Serigne Lo

Article2025

Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma

Serigne Lo, Caroline A. Gjorup, Annette H. Chakera, Lisbet Rosenkrantz Hölmich, Marc Moncrieff, Alastair D. MacKenzie Ross, Oliver Cassell, Jiawen Ma, Marie Brinch-Møller Weitemeyer, Roger Olofsson Bagge, Siri Klausen, Vinícius F. Calsavara, João Pedreira Duprat Neto, Eduardo Bertolli, Sydney Ch’ng, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Omgo E. Nieweg, Jonathan R. Stretch, Graham J. Mann, Jenny L. C. Geh, Lauren E. Haydu,

Article2023

Population-based validation of the melanoma institute australia (MIA) and the memorial sloan-kettering cancer center (MSKCC) predictive tool for sentinel node status in patients with melanoma.

Rasmus Mikiver, Roger Olofsson Bagge, Michael A. Marchetti, Alexander Christopher Jonathan Van Akkooi, Daniel G. Coit, Christian Ingvar, Karolin Isaksson, Richard A Scolyer, John F. Thompson, Alexander H. R. Varey, Johan Lyth, Edmund K. Bartlett

Article2020

Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data

M.A. El Sharouni, Tasnia Ahmed, Arjen J. Witkamp, V. Sigurdsson, Carla H. van Gils, Omgo E. Nieweg, Richard A Scolyer, John F. Thompson, P. J. van Diest, Serigne Lo

Article2009

Sentinel Node Status Prediction by Four Statistical Models

Simone Mocellin, John F. Thompson, Sandro Pasquali, Maria Cristina Montesco, Pierluigi Pilati, Donato Nitti, Robyn P.M. Saw, Richard A Scolyer, Jonathan R. Stretch, Carlo Riccardo Rossi